Cosentyx unoready 300 MG pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FCV4C
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $20,605
Award facts
- Contract value 100% obligated
- $20,605.10 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $20,605.10 delivery order to AmerisourceBergen Drug Corp for Cosentyx (secukinumab) 300 mg pen auto-injectors on December 17, 2025, with final delivery due by December 18, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs across military and veteran healthcare systems. The delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide.
Cosentyx is a biologic immunosuppressant used to treat autoimmune conditions including psoriasis, psoriatic arthritis, and ankylosing spondylitis. The order supports the Defense Health Agency and other federal healthcare customers' pharmaceutical supply needs. AmerisourceBergen's continued role as a primary vendor through the DLA's Pharmaceutical Prime Vendor Global Program reflects its demonstrated capability to meet federal competition requirements and deliver specialized pharmaceutical products across multiple therapeutic domains to support military medical operations.
Quick answers
Who was awarded contract SPE2DR26FCV4C?
SPE2DR26FCV4C was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 17, 2025.
How much is contract SPE2DR26FCV4C worth?
The government has obligated $20,605 on SPE2DR26FCV4C.
Is contract SPE2DR26FCV4C an order under another contract?
Yes. SPE2DR26FCV4C is a delivery order under SPE2DR25D1100, an indefinite delivery contract.
Was contract SPE2DR26FCV4C competed?
The extent of competition for SPE2DR26FCV4C was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award